Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2 | P10415 | 6/20 | 0.56 |
| ▸ | MCL1 | Q07820 | 6/20 | 0.56 |
| ▸ | ELANE | P08246 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | NPC1 | O15118 | 6/20 | 0.46 |
| ▸ | RAB9A | P51151 | 6/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.46 |
| ▸ | MAPT | P10636 | 5/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | CASP3 | P42574 | 2/20 | 0.46 |
| ▸ | SENP8 | Q96LD8 | 2/20 | 0.46 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.46 |
| ▸ | SENP6 | Q9GZR1 | 2/20 | 0.46 |
| ▸ | TTR | P02766 | 1/20 | 0.46 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.46 |
| ▸ | RELA | Q04206 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28612671 | 0.87 | ELANE (0.52) | BCL2MCL1ELANEALDH1A1NPC1 | |
| SCHEMBL11417173 | 0.83 | BCL2 (0.46) | BCL2MCL1ELANEALDH1A1NPC1 | |
| SCHEMBL10898977 | 0.81 | NPC1 (0.50) | BCL2MCL1ELANEALDH1A1NPC1 | |
| SCHEMBL11294862 | 0.79 | ELANE (0.55) | BCL2MCL1ELANEALDH1A1NPC1 | |
| SCHEMBL7905103 | 0.78 | BCL2 (0.70) | BCL2MCL1ELANEALDH1A1NPC1 | |
| SCHEMBL9811057 | 0.77 | ELANE (0.53) | BCL2MCL1ELANEALDH1A1NPC1 | |
| Anthraquinone SCHEMBL28812667 | 0.75 | MEN1 (0.71) | BCL2MCL1ELANEALDH1A1NPC1 | |
| SCHEMBL32662877 | 0.75 | EPHX1 (0.61) | CYP3A4TDP1TSHRMEN1KMT2A | |
| SCHEMBL4640609 | 0.75 | EPHX1 (0.61) | CYP3A4TDP1TSHRMEN1KMT2A | |
| SCHEMBL26187149 | 0.74 | NPC1 (0.55) | BCL2MCL1ELANEALDH1A1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025028353-A1 | NOVEL HETEROCYCLIC RING-CONTAINING MONOMER | エア・ウォーター・パフォーマンスケミカル株式会社 | 2025-02-06 | — | — | WO | disclosed |
| US-11958802-B2 | Migration-resistant photopolymerization sensitizer | KAWASAKI KASEI CHEMICALS LTD. (JP) | 2024-04-16 | — | — | US | disclosed |
| CN-113166036-B | Photopolymerizing sensitizers with migration resistance | 川崎化成工业株式会社 | 2023-10-10 | — | — | CN | disclosed |
| US-20230086413-A1 | PHOTORADICAL POLYMERIZABLE COMPOSITION | AIR WATER PERFORMANCE CHEMICAL INC. (JP) | 2023-03-23 | — | — | US | disclosed |
| US-11420928-B2 | Polymer photopolymerization sensitizer | KAWASAKI KASEI CHEMICALS LTD. (JP) | 2022-08-23 | — | — | US | disclosed |
| CN-110691765-B | High molecular photopolymerization sensitizer | 川崎化成工业株式会社 | 2022-05-17 | — | — | CN | disclosed |
| US-20220106254-A1 | MIGRATION-RESISTANT PHOTOPOLYMERIZATION SENSITIZER | KAWASAKI KASEI CHEMICALS LTD. (JP) | 2022-04-07 | — | — | US | disclosed |
| CN-113166036-A | Photopolymerisable sensitizers having migration resistance | 川崎化成工业株式会社 | 2021-07-23 | — | — | CN | disclosed |
| WO-2020213442-A1 | PHOTOPOLYMERIZABLE COMPOSITION, COATING FILM CONTAINING SAID PHOTOPOLYMERIZABLE COMPOSITION, AND CURING METHOD THEREFOR | 川崎化成工業株式会社 | 2020-10-22 | — | — | WO | disclosed |
| WO-2020209209-A1 | RADICAL PHOTOCURING OXYGEN INHIBITION REDUCER, RADICAL PHOTOPOLYMERIZABLE COMPOSITION CONTAINING RADICAL PHOTOCURING OXYGEN INHIBITION REDUCER, COATING CONTAINING RADICAL PHOTOCURING OXYGEN INHIBITION REDUCER, AND METHOD FOR CURING SAME | 川崎化成工業株式会社 | 2020-10-15 | — | — | WO | disclosed |
| WO-2020208833-A1 | PHOTO-RADICALLY CURABLE OXYGEN-INHIBITION-REDUCING AGENT, PHOTO-RADICALLY CURABLE OXYGEN-INHIBITION-REDUCING AGENT-CONTAINING PHOTO-RADICALLY POLYMERIZABLE COMPOSITION, PHOTO-RADICALLY CURABLE OXYGEN-INHIBITION-REDUCING AGENT-CONTAINING COATING FILM, AND METHOD FOR CURING SAME | 川崎化成工業株式会社 | 2020-10-15 | — | — | WO | disclosed |
| WO-2020121544-A1 | MIGRATION-RESISTANT PHOTOPOLYMERIZATION SENSITIZER | 川崎化成工業株式会社 | 2020-06-18 | — | — | WO | disclosed |
| WO-2020121384-A1 | PHOTOPOLYMERIZATION SENSITIZER HAVING MIGRATION RESISTANCE | 川崎化成工業株式会社 | 2020-06-18 | — | — | WO | disclosed |
| WO-2020054116-A1 | PHOTOPOLYMERIZATION SENSITIZER | 川崎化成工業株式会社 | 2020-03-19 | — | — | WO | disclosed |
| WO-2020054874-A1 | PHOTOPOLYMERIZATION SENSITIZER | 川崎化成工業株式会社 | 2020-03-19 | — | — | WO | disclosed |
| US-20200062692-A1 | POLYMER PHOTOPOLYMERIZATION SENSITIZER | KAWASAKI KASEI CHEMICALS LTD. (JP) | 2020-02-27 | — | — | US | disclosed |
| CN-110691765-A | High molecular photopolymerization sensitizer | 川崎化成工业株式会社 | 2020-01-14 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200062692-A1 | POLYMER PHOTOPOLYMERIZATION SENSITIZER | PCNA, RAD51, H1-10 | BCL2 610/4885MCL1 473/4885ELANE 2254/4885 |
| US-11420928-B2 | Polymer photopolymerization sensitizer | PCNA, RAD51, H1-10 | BCL2 610/4885MCL1 473/4885ELANE 2254/4885 |
| US-11958802-B2 | Migration-resistant photopolymerization sensitizer | F12, F10, PCNA | BCL2 1441/4885MCL1 544/4885ELANE 151/4885 |
| US-20220106254-A1 | MIGRATION-RESISTANT PHOTOPOLYMERIZATION SENSITIZER | F12, F10, PCNA | BCL2 1441/4885MCL1 544/4885ELANE 151/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.